y
Basic Information | |
---|---|
Species | Glycine max |
Cazyme ID | Glyma06g07040.2 |
Family | GT47 |
Protein Properties | Length: 475 Molecular Weight: 55207.2 Isoelectric Point: 8.2762 |
Chromosome | Chromosome/Scaffold: 06 Start: 5081831 End: 5084973 |
Description | Exostosin family protein |
View CDS |
External Links |
---|
NCBI Taxonomy |
Plaza |
CAZyDB |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 140 | 426 | 0 |
KLFKVYVYPDGDLPIVHDAPCKDIYSIEGRFLHEMEHGVGRFRTNDPTAAHVYFLPFSVTWMVKYFYSTPHSYDVTPLKNFVSDYVRVISTKYPFWNKTH GADHFMVACHDWGPYASEGNPFLYNTSIRVLCNANTSEGFNPQKDVPLPEIHLYGGEVSPKLLSPPPGNATRRYLAFFAGGMHGPIRPILLHHWNNRDIN DDMRVYEYLPKDLDYYSFMLNSKFCLCPSGYEVASPRIVESIYAECVPVILSKNYTLPFSDVLRWESFSVQVDVSDIPRLKEVLSAI |
Full Sequence |
---|
Protein Sequence Length: 475 Download |
MYKICRRRLF LFQFVLLFLW LILIEWLHPW QFIRFTESNP EYSVSLHQLR RHLFGQNQLR 60 ADGDAAAAAH SNNTTVTRDV VRVNIREEKR EEGLARARAA MRIAALTGTN LTTHDNDDIL 120 AGTVYRNPRL FHQSYLEMEK LFKVYVYPDG DLPIVHDAPC KDIYSIEGRF LHEMEHGVGR 180 FRTNDPTAAH VYFLPFSVTW MVKYFYSTPH SYDVTPLKNF VSDYVRVIST KYPFWNKTHG 240 ADHFMVACHD WGPYASEGNP FLYNTSIRVL CNANTSEGFN PQKDVPLPEI HLYGGEVSPK 300 LLSPPPGNAT RRYLAFFAGG MHGPIRPILL HHWNNRDIND DMRVYEYLPK DLDYYSFMLN 360 SKFCLCPSGY EVASPRIVES IYAECVPVIL SKNYTLPFSD VLRWESFSVQ VDVSDIPRLK 420 EVLSAIPESE YQKLKHGVRA VRRHFTLNQP AKRLDVFHMI LHSIWLRRLD IDLR* 480 |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 4.0e-65 | 138 | 426 | 308 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |
Annotations - NR Download unfiltered results here | |||||||
---|---|---|---|---|---|---|---|
Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
EMBL | CBI21064.1 | 0 | 28 | 473 | 29 | 477 | unnamed protein product [Vitis vinifera] |
RefSeq | NP_197913.4 | 0 | 30 | 473 | 37 | 479 | catalytic [Arabidopsis thaliana] |
RefSeq | XP_002285237.1 | 0 | 138 | 473 | 1 | 333 | PREDICTED: hypothetical protein [Vitis vinifera] |
RefSeq | XP_002324871.1 | 0 | 138 | 473 | 1 | 333 | predicted protein [Populus trichocarpa] |
RefSeq | XP_002515489.1 | 0 | 15 | 473 | 20 | 480 | catalytic, putative [Ricinus communis] |
Metabolic Pathways | |||
---|---|---|---|
Pathway Name | Reaction | EC | Protein Name |
xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |